Atacama Therapeutics
Wellesley, US · Delaware corporation
Founders & leadership
JB
Joseph BaronNamed on SEC filing
JR
Jonathan ReisNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$830K disclosed across 1 round · 2024
▶$830KraisedMay 2024 · 16 investors · Other Health CareRule 506(b)
▶$830KraisedMay 2024 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph BaronExecutive Officer, Director
- Jonathan ReisDirector
- Offering amount
- $4.7M
- Amount sold
- $830K
- Minimum investment
- $2.5K
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Atacama Therapeutics raised?
- Atacama Therapeutics has disclosed $830K raised across 1 round.
- Where is Atacama Therapeutics headquartered?
- Atacama Therapeutics is headquartered in Wellesley, US.